by RIVANNA | Sep 8, 2025 | Video
Military medical device development requires more than adapting existing technology; it demands understanding operational realities from the ground up. The Accuro 3S-MIL development process exemplified this approach through a comprehensive 36-month timeline that...
by RIVANNA | Sep 8, 2025 | News
By Paul Sheeran, Ph.D. — Director of Research & Development at RIVANNA For over a decade, RIVANNA has been at the forefront of imaging innovation, developing AI-driven procedural guidance to improve clinical outcomes. Now, with the support of a $3M...
by RIVANNA | Sep 8, 2025 | Press Releases
CHARLOTTESVILLE, VA, SEPTEMBER 8, 2025 — RIVANNA®, developers of world-first imaging-based medical technologies, has recently been awarded with a Peer-Reviewed Medical Research Program (PRMRP) Technology/Therapeutic Development Award (TTDA) from the Congressionally...
by RIVANNA | Sep 3, 2025 | News
The tech industry is continuing to advance their AI tools, such as large language models (LLMs) and beyond, in leaps and bounds. These tools are beginning to have major impacts in many areas, such as education, the workplace, and healthcare. The healthcare field is...
by RIVANNA | Sep 2, 2025 | Press Releases
CHARLOTTESVILLE, VA, SEPTEMBER 2, 2025 — RIVANNA®, developers of world-first imaging-based medical technologies, has been awarded a $2.21 million Small Business Innovation Research (SBIR) Direct to Phase II (R44) grant from the National Cancer Institute (NCI) of the...
